Cerebrospinal fluid monoamine metabolites and suicide

Nordic Journal of Psychiatry

Volumn 61, Issue 3, 2007, Pages 233-234

  Sher, Leo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DOPAMINE RECEPTOR; HOMOVANILLIC ACID; MONOAMINE; BIOLOGICAL MARKER;

BIPOLAR DISORDER; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; HUMAN; LETTER; MONOAMINE METABOLISM; NEUROBIOLOGY; NEUROIMAGING; RELIABILITY; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; CEREBROSPINAL FLUID; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; STATISTICS;

BIOLOGICAL MARKERS; DEPRESSIVE DISORDER; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; PREDICTIVE VALUE OF TESTS; SUICIDE; SUICIDE, ATTEMPTED;

EID: 34547684723     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.1080/08039480701352751     Document Type: Letter

References (14)

1. Samuelsson, M., Jokinen, J., Nordström, A-L and Nordström, P. (2006) CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. Acta Psychiatr Scand, 113, pp. 44-47.
2. Sher, L. and Mann, JJ. (2003) Neurobiology of suicide. Textbook of medical psychiatry, pp. 701-711. Marcel Dekker, New York
3. Geracioti, TDJr, Keck, PEJr, Ekhator, NN, West, SA, Baker, DG and Hill, KK (1998) Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid. Biol Psychiatry, 44, pp. 228-233.
4. Sher, L., Oquendo, MA, Huang, Y., Grunebaum, MF and Burke, AK (2003) Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism. Neuropsychopharmacology, 28, pp. 1712-1719.
5. Traskman, L., Asberg, M., Bertilsson, L. and Sjostrand, L. (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry, 38, pp. 631-636.
6. Engströ;m, G., Alling, C., Blennow, K., Regnell, G. and Traskman-Bendz, L. (1999) Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur Neuropsychopharmacol, 9, pp. 399-405.
7. Roy, A., Agren, H., Pickar, D., Linnoila, M., Doran, AR and Cutler, NR (1986) Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: Relationship to suicidal behavior and dexamethasone nonsuppression. Am J Psychiatry, 143, pp. 1539-1545.
8. Jones, JS, Stanley, B., Mann, JJ, Frances, AJ, Guido, JR and Traskman-Bendz, L. (1990) CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Am J Psychiatry, 147, pp. 1225-1227.
9. Roy, A., De Jong, J. and Linnoila, M. (1989) Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Arch Gen Psychiatry, 46, pp. 609-612.
10. Traskman-Bendz, L., Alling, C., Alsen, M., Regnell, G., Simonsson, P. and Ohman, R. (1993) The role of monoamines in suicidal behavior. Acta Psychiatr Scand, 371, pp. 45-47.
11. Montgomery, SA and Montgomery, D. (1982) Pharmacological prevention of suicidal behaviour. J Affect Disord, 4, pp. 291-298.
12. Agren, H. (1983) Life at risk: Markers of suicidality in depression. Psychiatr Dev, 1, pp. 87-103.
13. Sher, L. Bipolar Disord. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder
14. Sher, L., Mann, JJ, Traskman-Bendz, L., Huang, Y., Fertuck, EA and Stanley, BH. (2006) Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters. J Affect Disord, 90, pp. 83-89.